Canadian Immigration Updates

Applicants to Master’s and Doctoral degrees are not affected by the recently announced cap on study permits. Review more details

Every day across British Columbia, trainees and researchers at the UBC Faculty of Medicine are turning skills into jobs, investments into discoveries, and discoveries into solutions that are transforming health for everyone.

Ranked among the world’s top medical schools with the fifth-largest MD enrollment in North America, the UBC Faculty of Medicine is a leader in both the science and the practice of medicine. Across British Columbia, more than 12,000 faculty and staff are training the next generation of doctors, health care professionals, and medical researchers, making remarkable discoveries to help create the pathways to better health for our communities at home and around the world.

The UBC Faculty of Medicine offers a diverse array of training opportunities including cutting-edge research experiences in the biosciences, globally recognized population health education, quality health professional training, as well as several certificate and online training options. The Faculty of Medicine is home to more than 1,700 graduate students housed in 20 graduate programs (14 of which offer doctoral research options). Year after year, research excellence in the Faculty of Medicine is supported by investment from funding sources here at home and around the globe, receiving approximately more than $1.8B in total research funding since 2016.

We value our trainees and the creative input they have to scholarly activities at UBC. Our priority is to enable their maximum potential through flexible opportunities that provide a breadth of experiences tailored to their own individual career objectives. We maintain high standards of excellence, and work to create a community of intellectually and socially engaged scholars that work collaboratively with each other, the university, and the world, with the overarching goal of promoting the health of individuals and communities.

 

Research Facilities

UBC Faculty of Medicine provides innovative educational and research programs in the areas of health and life sciences through an integrated and province-wide delivery model in facilities at locations throughout British Columbia.

The Life Sciences Centre is the largest building on the UBC Vancouver campus. Completed in 2004, the $125 million, 52,165 sq metres building was built to accommodate the distributed medical educational program and the Life Sciences Institute.

The Djavad Mowafaghian Centre for Brain Health (DMCBH), a partnership between the University of British Columbia and Vancouver Coastal Health, unites under one roof research and clinical expertise in neuroscience, psychiatry and neurology in order to accelerate discovery and translate new knowledge into better treatment and prevention strategies. DMCBH has both laboratory and clinical research areas within the Centre proper and in the UBC Hospital Koerner Pavilion. Our core facilities are essential to ongoing collaboration, teaching, and research.

The BC Children's Hospital Research Institute is it the largest research institute of its kind in Western Canada in terms of people, productivity, funding and size. With more than 350,000 square feet of space, the Institute has both 'wet bench' laboratory and 'dry lab' clinical research areas, and other areas to facilitate particular areas of research and training.

Research Highlights

New knowledge and innovation are crucial to successfully identifying, addressing and overcoming the increasingly complex health-related challenges that influence the lives of all of us – in British Columbia, in Canada, and in countries and communities around the globe.

The UBC Faculty of Medicine is recognized nationally and internationally for research innovation that advances knowledge and translates new discoveries to improve the health and well-being of individuals and communities. Research opportunities feature extensive collaborations across other faculties, health institutions and health partners across British Columbia, Canada and internationally.

The Faculty provides and fosters research excellence across the full continuum, from basic science to applied science and then to knowledge implementation, with a focus on precision health; cancer; brain and mental health; heart and lung health; population health; and chronic diseases.

Graduate Degree Programs

Recent Publications

This is an incomplete sample of recent publications in chronological order by UBC faculty members with a primary appointment in the Faculty of Medicine.

 

Recent Thesis Submissions

Doctoral Citations

A doctoral citation summarizes the nature of the independent research, provides a high-level overview of the study, states the significance of the work and says who will benefit from the findings in clear, non-specialized language, so that members of a lay audience will understand it.
Year Citation Program
2020 Dr. Khorvash determined computationally how an antibody specific towards Alzheimer's disease (AD) detects its toxic species, amyloid beta oligomers. The target regions were used to design a smaller version of the antibody and to predict the binding sites of oligomers on the surface of neurons, which can be used to design more effective antibodies. Doctor of Philosophy in Experimental Medicine (PhD)
2020 Dr. Afshar explored the benefits that individuals with diabetes receive from delivering support to peers with the same health condition in peer support interventions. She proposed how to optimize these programs and maximize these benefits, which will help patients with diabetes, researchers, and policymakers designing peer support interventions. Doctor of Philosophy in Experimental Medicine (PhD)
2020 Dr. Eisner examined a population of progenitor cells present in the adult skeleton to determine their roles in bone homeostasis and regeneration, and identified a signaling pathway crucial to maintain the normal function of these progenitors. This work furthers our understanding of bone biology and presents potential targets for skeletal therapies. Doctor of Philosophy in Experimental Medicine (PhD)
2020 Dr. Ennis determined the dietary requirements for amino acids phenylalanine and tyrosine in human pregnancy, while comparing findings to current management practices of maternal phenylketonuria patients. These studies will improve dietary recommendations during pregnancy that have the potential to positively impact birth outcomes. Doctor of Philosophy in Reproductive and Developmental Sciences (PhD)
2020 Dr. Jabalee examined the molecular changes that occur during cancer progression. He identified silencing of the SMPD3 gene as a driver of cell motility and demonstrated the presence of morphological alterations in non-cancer cells adjacent to tonsil tumors. This work opens the door to development of novel tests for early tumor detection. Doctor of Philosophy in Interdisciplinary Oncology (PhD)
2020 Dr. Mathae discovered the role of an immune cell population in sex bias in asthma prevalence. She also found that these cells migrate from the lung to the liver upon activation, linking the lung and liver immunity. Her work highlights the complexity of the local and systemic immune regulations. Doctor of Philosophy in Interdisciplinary Oncology (PhD)
2020 Dr. Palis studied cocaine use among patients receiving treatment for opioid addiction at North America's first injectable opioid agonist treatment clinic. Her dissertation quantified and explained variation in patients' patterns of cocaine use. These findings can inform treatment and service provision for people who use both cocaine and opioids. Doctor of Philosophy in Population and Public Health (PhD)
2020 Dr. Yue developed economical, high-throughput research techniques to track hundreds of cell signalling proteins in biological models with high sensitivity. He then applied these to map the architecture of signalling systems involved in cancer, diabetes and Alzheimer's disease to uncover potential therapeutic and diagnostic opportunities. Doctor of Philosophy in Experimental Medicine (PhD)
2020 Dr. Davies studied the user interface design aspects of how to best present large and complex patient genomic data at the point of care to improve frailty risk assessment. Her research is a step towards integrating big data into routine primary care usage. Doctor of Philosophy in Experimental Medicine (PhD)
2020 Dr. Samiea studied the role of Interleukin-10, an anti-inflammatory regulator, on immune and cancer cells. She found that its action is not limited to immune cells deactivation but it can also contribute to prostate cancer progression. Her findings will aid on the development of new therapies for inflammatory diseases and prostate cancer. Doctor of Philosophy in Experimental Medicine (PhD)

Pages